Imidazoles and benzimidazoles as putative inhibitors of SARS-CoV-2 B.1.1.7 (Alpha) and P.1 (Gamma) variant spike glycoproteins: A computational approach

COVID-19 is an unprecedented pandemic threatening global health, and variants were discovered rapidly after the pandemic. The two variants, namely the SARS-CoV-2 B.1.1.7 (Alpha) and P.1 (Gamma), were formed by the mutations in the receptor binding domain of spike glycoprotein (SGP). These two varian...

Descripción completa

Detalles Bibliográficos
Autores principales: Yele, Vidyasrilekha., Sanapalli, Bharat Kumar Reddy., Mohammed, Afzal Azam.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Versita 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522534/
https://www.ncbi.nlm.nih.gov/pubmed/34690413
http://dx.doi.org/10.1007/s11696-021-01900-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522534/
https://www.ncbi.nlm.nih.gov/pubmed/34690413
http://dx.doi.org/10.1007/s11696-021-01900-8

Ejemplares similares